1. Home
  2. OFS vs IZTC Comparison

OFS vs IZTC Comparison

Compare OFS & IZTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OFS
  • IZTC
  • Stock Information
  • Founded
  • OFS 2001
  • IZTC 2019
  • Country
  • OFS United States
  • IZTC United States
  • Employees
  • OFS N/A
  • IZTC N/A
  • Industry
  • OFS Finance/Investors Services
  • IZTC Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • OFS Finance
  • IZTC Health Care
  • Exchange
  • OFS Nasdaq
  • IZTC Nasdaq
  • Market Cap
  • OFS 108.5M
  • IZTC 111.5M
  • IPO Year
  • OFS 2012
  • IZTC 2024
  • Fundamental
  • Price
  • OFS $8.10
  • IZTC $17.54
  • Analyst Decision
  • OFS
  • IZTC
  • Analyst Count
  • OFS 0
  • IZTC 0
  • Target Price
  • OFS N/A
  • IZTC N/A
  • AVG Volume (30 Days)
  • OFS 31.1K
  • IZTC 38.3K
  • Earning Date
  • OFS 03-03-2025
  • IZTC 02-15-2025
  • Dividend Yield
  • OFS 16.80%
  • IZTC N/A
  • EPS Growth
  • OFS N/A
  • IZTC N/A
  • EPS
  • OFS N/A
  • IZTC N/A
  • Revenue
  • OFS $49,799,000.00
  • IZTC N/A
  • Revenue This Year
  • OFS N/A
  • IZTC N/A
  • Revenue Next Year
  • OFS N/A
  • IZTC N/A
  • P/E Ratio
  • OFS N/A
  • IZTC N/A
  • Revenue Growth
  • OFS N/A
  • IZTC 145.01
  • 52 Week Low
  • OFS $7.75
  • IZTC $8.50
  • 52 Week High
  • OFS $11.94
  • IZTC $23.00
  • Technical
  • Relative Strength Index (RSI)
  • OFS 50.99
  • IZTC N/A
  • Support Level
  • OFS $7.92
  • IZTC N/A
  • Resistance Level
  • OFS $8.17
  • IZTC N/A
  • Average True Range (ATR)
  • OFS 0.10
  • IZTC 0.00
  • MACD
  • OFS 0.01
  • IZTC 0.00
  • Stochastic Oscillator
  • OFS 84.00
  • IZTC 0.00

About OFS OFS Capital Corporation

OFS Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its business objective is to generate current income and capital appreciation by investing in middle-market companies in the United States. The company focuses on investments in senior secured loans, including first lien, second lien, and unitranche loans, as well as subordinated loans and, to a lesser extent, warrants, and other equity securities.

About IZTC Invizyne Technologies Inc. Common Stock

Invizyne Technologies Inc is redefining biomanufacturing by leveraging cell-free multi-step enzyme-based systems to efficiently transform natural or renewable resources into highly sought-after chemicals. It believes that its biomanufacturing platform, known as SimplePath, will be a significant alternative to the current methods of chemical compound production, which are generally chemical synthesis, natural extraction, and synthetic biology. its objective with SimplePath is to enable the efficient production of a diverse range of chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform consists of a series of modular cascading enzyme-based biomanufacturing systems that leverage natural processes to perform complex chemical conversions.

Share on Social Networks: